The Pharmacology Center

Filter Your Results

 

News

 

BioCardia Begins CardiAMP Pivotal Heart Failure Trial

January 3, 2017 -- BioCardia, Inc. announced the initiation of the CardiAMP Heart Failure pivotal trial. According to the company, the randomized controlled multicente…

EMIT-AF/VTE Registry Initiated to Evaluate Daiichi Sankyo's Lixiana

December 13, 2016 -- Daiichi Sankyo Europe GmbH announced that the first patient has been enrolled in the EMIT-AF/VTE registry, which will collect real-world clinical dat…

Study Finds Heparin Plus Short-Term Tirofiban Similar to Bivalirudin in Safety and Efficacy for PCI

November 17, 2016 -- A recent study has shown that two short-term blood clot prevention medications, heparin plus short-term tirofiban and bivalirudin, are both safe and effec…

PIONEER AF-PCI Results Presented for Xarelto in NVAF Patients After PCI With Stenting

November 14, 2016 -- Janssen Pharmaceuticals, Inc. announced new phase 3b results from the PIONEER AF-PCI study of the company’s Xarelto (rivaroxaban) compared to w…

Bivalirudin Compared With Unfractionated Heparin for PCI in STEMI Patients

November 11, 2016 -- Findings from a study conducted to describe temporal trends and determine the comparative effectiveness of bivalirudin versus unfractionated heparin (UFH)…

Expert Consensus Statement Addresses Anesthesia Practices in Pediatric Congenital Cath Labs

November 11, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA), and the Congenital Cardiac Anesthesia Soc…

Two-Year LEADERS FREE Data Presented for BioSensors’ BioFreedom Drug-Coated Stent

October 30, 2016 -- The 2-year results from LEADERS FREE were reported at TCT 2016, the 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Was…

Two Real-World Studies Evaluate Xarelto in Treating VTE

October 23, 2016 -- Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, announced results of two real-world studies confirming the benefit-risk profil…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.